Hemogenyx Pharmaceuticals (LSE:HEMO) FCF Yield % : -31.76 (As of May. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hemogenyx Pharmaceuticals's Trailing 12-Month Free Cash Flow is £-6.22 Mil, and Market Cap is £19.59 Mil. Therefore, Hemogenyx Pharmaceuticals's FCF Yield % for today is -31.76%.

The historical rank and industry rank for Hemogenyx Pharmaceuticals's FCF Yield % or its related term are showing as below:

LSE:HEMO' s FCF Yield % Range Over the Past 10 Years
Min: -31.76 Med: 0 Max: 0
Current: -31.76

LSE:HEMO's FCF Yield % is ranked worse than
68.51% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs LSE:HEMO: -31.76

Hemogenyx Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Hemogenyx Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Hemogenyx Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemogenyx Pharmaceuticals FCF Yield % Chart

Hemogenyx Pharmaceuticals Annual Data

Trend

Feb15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-17.21

-4.71

-18.75

-25.73

-23.02

Hemogenyx Pharmaceuticals Semi-Annual Data
	Feb15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial												-25.33	-14.74	-36.98	-38.90	-20.90

Competitive Comparison of Hemogenyx Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Hemogenyx Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemogenyx Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemogenyx Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hemogenyx Pharmaceuticals's FCF Yield % falls into.

Hemogenyx Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hemogenyx Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-6.223	/	27.03811
	=	-23.02%

Hemogenyx Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.825	*	2	/	27.03811
	=	-20.90%

Hemogenyx Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Hemogenyx Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hemogenyx Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemogenyx Pharmaceuticals (LSE:HEMO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

5HU:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.hemogenyx.com

Hemogenyx Pharmaceuticals PLC is a operator of a biotechnology company intended to focus on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukaemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy, its three distinct products include an immunotherapy product for the treatment of relapsed/refractory acute myeloid leukaemia (AML) and patient conditioning, the bi-specific antibody, for the treatment of AML and a community-based rehabilitation / Biomedical engineering platform, enabling users to generate treatments for existing and emerging viral infections.

Hemogenyx Pharmaceuticals (LSE:HEMO) Headlines

No Headlines